In conclusion, our study provides important information about the potential therapeutic attractiveness of antibodies against TGF-β and Activin A, but not Gremlin 1, to inhibit self-supported growth and proliferation of human PAH PAVSMC. The gene discussed is GREM1; the disease is pulmonary arterial hypertension.